53 / 330
53
19–22 APRIL, 2017, BARCELONA, SPAIN
S5: VESICOURETERAL REFLUX 2
Moderators: Francisco Reed (Chile), Abraham Cherian (UK)
ESPU Meeting on Thursday 20, April 2017, 08:56–09:32
08:56–08:59
S5-1 (PP)
★
COMPARING THE OUTCOMES OF ANTIREFLUX
SURGERY WITH SUBMUCOSAL INJECTION IN CHILDREN
WITH VESICOURETERAL REFLUX
Fahimeh KAZEMI RASHED
1
, Mohammadreza ROSHANDEL
2
and Tannaz AGAYI
2
1) Tabriz University of Medical Sciences, Urology, Tabriz, ISLAMIC REPUBLIC OF IRAN - 2) Tabriz University of Medical
Sciences, Urology, Tabriz, ISLAMIC REPUBLIC OF IRAN
PURPOSE
The treatment goal of vesicoureteral reflux is to preserve renal function by reducing the risk of infec-
tion and renal scarring. In this study we compare two kind of anti reflux treatment: Open antireflux
surgery and endoscopic injection of vantris .
MATERIAL AND METHODS
In a clinical trial, 61 patients (100 renal units) with Vesicoureteral reflux based on pre-determined
inclusion and exclusion criteria, divided into two groups of Gil Vernet open surgery Vantris injection
and the results were compared.
RESULTS
Demographic characteristics, Clinical symptoms, laboratory examination results of both groups
were same. The duration of follow-up in Vantris group was 8.81±1.65 months (1 to 22) and in the
surgical group was 7.57±0.89 months (3 to 26)(P=0.47).
Recovery and non-recovery after treatment in the Vantris group, was 48(98%) and 1(2%), respec-
tively, and in the surgical group was 47(96%) and 3 cases(4%)(P=0.62).
Full recovery after treatment in the Vantris group was in 40(81.6%) and in the surgical group, in
43(86%)(P=0.56).
After treatment, VUR occurred in the opposite side in the Vantris group in one case (3.2%) and in
the surgical group in two cases (6.7%)(P=0.61).
CONCLUSIONS
In the current study, the success rate of endoscopic treatment of VUR after the first injection of
Vantris in patients with II to IV reflux were compared with those treated with Gil-Vernet open surgery
methods. Accordingly, complete remission and overall recovery was observed in 81.6% and 98% in
the Vantris group and in 86% and 94% in the open surgery group, respectively (with no significant
difference).